Exelixis Announces Update on Patent Litigation with MSN Laboratories
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- US stock futures mixed as Apple slides, midterms loom
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Exelixis, Inc. (NASDAQ: EXEL) | Delayed: 70.13 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $70.13 | 52 Week High | $17.00 | |||
| Open | $70.13 | 52 Week Low | $3.55 | |||
| Day High | $70.13 | P/E | N/A | |||
| Day Low | $70.13 | EPS | $-1.33 | |||
| Volume | 28 | |||||
